SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark signs strategic agreement with Particle Sciences

19 Sep 2016 Evaluate

Glenmark Pharmaceuticals, USA has entered into a strategic Development, License and Commercialization agreement with Particle Sciences Inc. to develop and market a generic version of Celgene’s ABRAXANE product – paclitaxel protein (albumin)-bound particles for injectable suspension. As per the terms of the agreement, the company has obtained Global Exclusive Marketing and Distribution rights of the product upon commercialization.

Particle Sciences will develop this product exclusively for Glenmark shall receive certain milestone payments during various stages of the product’s development from the company, including royalties on sales. Development of the product has been initiated for the USA market and the company intends to file the ANDA in FY19. The product will be subsequently filed in other key markets across the globe.

Glenmark’s current portfolio consists of 109 products authorized for distribution in the US marketplace and 62 ANDA’s pending approval with the US FDA. In addition to these internal filings, the company continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

2229.65 -18.25 (-0.81%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×